Imatinib Not Yet Recruiting Phase 0 Trials for Chronic Myeloid Leukemia (CML) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment0
clinicaltrials.gov IdentifierTitleDrugs
NCT03228303Nilotinib Versus Imatinib in Treatment of Patients With Newly Diagnosed Chronic Myeloid Leukemia